| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 281.98B | 279.19B | 266.81B | 251.57B | 215.88B | 193.40B |
| Gross Profit | 84.62B | 82.18B | 77.77B | 71.25B | 62.74B | 47.63B |
| EBITDA | 46.30B | 44.89B | 40.28B | 32.33B | 33.35B | 21.86B |
| Net Income | 22.94B | 22.12B | 18.55B | 13.74B | 14.54B | 8.71B |
Balance Sheet | ||||||
| Total Assets | 382.00B | 371.51B | 391.30B | 345.88B | 332.62B | 307.33B |
| Cash, Cash Equivalents and Short-Term Investments | 67.10B | 68.72B | 77.92B | 59.58B | 55.44B | 48.06B |
| Total Debt | 25.15B | 27.24B | 30.86B | 35.62B | 39.23B | 43.20B |
| Total Liabilities | 115.93B | 109.35B | 130.74B | 119.29B | 122.86B | 119.83B |
| Stockholders Equity | 263.80B | 259.81B | 258.40B | 224.40B | 207.76B | 185.79B |
Cash Flow | ||||||
| Free Cash Flow | 15.57B | 8.14B | 27.74B | 12.43B | 13.00B | 18.17B |
| Operating Cash Flow | 29.02B | 21.30B | 38.58B | 21.35B | 21.00B | 27.89B |
| Investing Cash Flow | -7.52B | -11.83B | -9.16B | -9.28B | -9.07B | -9.56B |
| Financing Cash Flow | -19.81B | -21.66B | -15.70B | -9.96B | -7.78B | -4.35B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | ¥255.76B | 9.64 | 8.91% | 3.85% | 1.48% | 8.86% | |
78 Outperform | ¥112.83B | 15.71 | ― | 4.64% | 3.99% | -28.28% | |
71 Outperform | ¥542.64B | 28.49 | 5.25% | 2.13% | -2.23% | 130.96% | |
67 Neutral | ¥7.30B | 3.03 | ― | 1.37% | -3.05% | ― | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
58 Neutral | ¥399.97B | 197.68 | 5.94% | 0.56% | 6.22% | ― | |
55 Neutral | ¥593.82B | -6.48 | 1.88% | 6.16% | 1.98% | -48.28% |